Socially sanctioned coercion mechanisms for addiction treatment

American Journal on Addictions

Volumn 16, Issue 1, 2007, Pages 15-23

  Nace, Edgar P ^a,b   Birkmayer, Florian ^c   Sullivan, Maria A ^d,k   Galanter, Marc ^e   Fromson, John A ^f   Frances, Richard J ^e   Levin, Frances R ^d   Lewis, Collins ^g   Suchinsky, Richard T ^h   Tamerin, John S ^b   Westermeyer, Joseph ^i,j  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of New Mexico ^*

^c UNIVERSITY OF NEW MEXICO   (United States)

^d School of Medicine ^*  (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f METROWEST MEDICAL CENTER   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h DEPARTMENT OF VETERANS AFFAIRS   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j UNIVERSITY OF MINNESOTA   (United States)

^k NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; DISABILITY; DRUG DEPENDENCE; HEALTH INSURANCE; INVOLUNTARY COMMITMENT; MANDATORY PROGRAM; PERSUASIVE COMMUNICATION; REVIEW; SOCIAL SECURITY; WORKPLACE;

EID: 33847373746     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490601077783     Document Type: Review

References (75)

1. Winick C, Norman RL. Epidemiology. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. Fourth edition. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005:841-862.
2. Pridemore WA. Weekend effects on binge drinking and homicide: the social connection between alcohol and violence in Russia. Addiction. 2004;99:1034-1041.
3. Borges G, Cheripitel CJ, MacDonald S, Giesbrecht N, Stockwell T, Wilcox HC. A case-crossover study of acute alcohol use and suicide attempt. J Stud Alcohol. 2004;65:708-714.
4. Ferguson DM, Swain-Campbell NR, Horwood LJ. Deviant peer affiliations, crime and substance use: a fixed effects regression analysis. J Abnorm Child Psychol. 2002;30:419-430.
5. Chernack ST, Blow FC. Violence among individuals in substance abuse treatment: the role of alcohol and cocaine consumption. Drug Alcohol Depend. 2002;66:29-37.
6. Parrott DJ, Drobes DJ, Saladin ME, Coffey SF, Dansky BS. Perpetration of partner violence: effects of cocaine and alcohol dependence and posttraumatic stress disorder. Addict Behav. 2003;28:1587-1602.
7. Fals-Stewart W, Golden J, Schumacker JA. Intimate partner violence and substance use: a longitudinal day-to-day examination. Addict Behav. 2003;28:1555-1574.
8. Taylor BG, Fitzgerald N, Hunt D, Reardon J, Brownstein H. Adam Preliminary 2000 Findings on Drug Use and Drug Markets. Washington, DC: National Institute of Justice; 2001.
9. Office of Applied Studies. Summary of Findings from the 2000 National House Household Survey on Drug Abuse. Rockville, Md.: US Department of Health and Human Services; 2001.
10. Wechlser H, Dowdall GW, Maenner G, Gledhill-Hoyt J, Lee H. Changes in binge drinking and related problems among American college students between 1993 and 1997. Results of the Harvard School of Public Health College Alcohol Study. J Am Coll Health. 1998;47:57-68.
11. Cashin JR, Presley CA, Meilman PW. Alcohol use in the Greek system: follow the leader? J Stud Alcohol. 1998;59:63-70.
12. National Institute of Drug Abuse. National Pregnancy and Health Survey. Rockville, Md.: US Department of Health and Human Services; 1996.
13. Gourevitch P, Arnsten JH. Medical complications of drug use. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. Fourth edition. Philadelphia, Pa: Lippincott Williams; 2005:841-862.
14. Galanter MN, Kleber HD. Textbook of Substance Abuse Treatment. Third edition. Washington, DC: The American Psychiatric Publishing; 2004.
15. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159:1642-1652.
16. Galanter M, Keller D, Dermatis H, Egelko S. The impact of managed care on substance abuse treatment: a report of the American Society of Addiction Medicine. J Addict Dis. 2000;19:13-34.
17. O'Brien CP. Myths about the treatment of addiction. Lancet. 1996;347:237-240.
18. Group for the Advancement of Psychiatry, Committee on Addictions. Responsibility and choice in addiction. Psychiatric Services. 2002;53:707-713.
19. Harwood H. Updating estimates of the economic costs of alcohol abuse in the United States: Estimates, update methods and data. Reports prepared by the Levin Group for the National Institute on Alcohol Abuse and Alcoholism; 2000.
20. Bazelon DL. Position Statement on Involuntary Commitment. Washington, DC: Judge David L. BazelonCenter forMental Health Law; 2000.
21. NAMI. Involuntary Commitment and Court Mandated Treatment. Arlington, Va.: NAMI; 1995.
22. Ridgely SM, Borum R, Petrila J. The Effectiveness of Involuntary Outpatient Treatment. Santa Monica, Calif.: Rand Corporation; 2001.
23. Anglin MD, Brecht ML, Maddahiam E. Pretreatment characteristics and treatment performance of legally coerced versus voluntary methadone maintenance admissions. Criminology. 1989;27:537-552.
24. Chankin DF. For their own good: civil commitment of alcohol and drug-dependent women. South Dakota Law Review. 1992;37:224-228.
25. Dunham RG, Maurs AL. Reluctant referrals: the effectiveness of legal coercion in outpatient treatment for problem drinkers. Journal of Drug Issues. 1982;12:5-20.
26. Nichols JL, Ross HL. The effectiveness of legal sanctions in dealing with drinking drivers. Alcohol, Drug, and Driving. 1990;6:33-60.
27. Sereny G, Sharma V, Holb J, Gurdis F. Mandatory supervised Antabuse therapy in an outpatient alcoholism program: a pilot study. Alcohol Clin Exp Res. 1986;10:290-292.
28. Drug Courts Resource Series. Guideline for Drug Courts on Screening and Assessment. Prepared for the American University, Justice Programs Office, in association with the U.S. Department of Justice, Office of Justice Programs, Drug Courts Program Office; Washington, DC; 1998.
29. CSAT. Contracting for Managed Substance Abuse and Mental Health Services: A Guide for Public Purchasers: Treatment Assistance Protocol (TAP) 22. Rockville, Md.: Center for Substance Abuse Treatment; 1998.
30. Kitzman J. Survey of Statutes Allowing Involuntary Commitment for Drug and Alcohol Dependent Persons. Charlottesville, Va.: The Institute of Law, Psychiatry and Public Policy; 1997.
31. U.S. Supreme Court, Robinson v California, 370 U.S. 660 (1962).
32. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive involvement of the orbito-frontal cortex. Cereb Cortex. 2000;10:318-325.
33. Cooper CA, Bartlett SR, Shaw MA, Yang KK. Drug Courts: 1997 Overview of Operational Characteristics and Implementation Issues. Vol. 1. American University Drug Court Clearinghouse and Technical Assistance Project. Washington, DC: Office of Justice Programs, U.S. Department of Justice; 1997.
34. American University. Looking at a Decade of Drug Courts. Prepared by the Drug Court Clearinghouse and Technical Assistance Project. U.S. Department of Justice, Office of Justice Programs; Washington, DC; 1999.
35. Harrell A, Cavanaugh S. Preliminary Results from the Evaluation of the DC. Superior Court Drug Intervention Program for Drug Felony Defendants. Washington, DC.: The Urban Institute; 1997.
36. Drug Court Resource Series. Practical Guide for Applying Federal Confidentiality Laws to Drug Court Operations. Prepared by the Drug Court Clearinghouse and Technical Assistance Project. U.S. Department of Justice, Office of Justice Programs; 1999.
37. Satel S. Drug treatment: the case for coercion. National Drug Court Institute Review. 2000;3:1-56.
38. Goldkamp JS, Weiland D. Assessing the Impact of Dade County's Felony Drug Court: Final Report. National Institute of Justice; 1993.
39. McAlarney BP (ed.) Drug court analysis: Higher upfront costs yield major savings. Alcoholism and Drug Abuse Weekly. March 8, 2004;16(10):1-3
40. Roman PM, Blum TC. Effectiveness of workplace alcohol problem interventions. Am J Health Promot. 1996;11:112-128.
41. Mack A, Franklin JE, Frances RJ. Concise Guide to the Treatment of Alcoholism and Addictions. Washington, DC: American Psychiatric Press; 2001.
42. CALDATA. State of California Publication No. (ADP) 94-4620. Ann Arbor, MI: The California Drug and Alcohol Treatment Assessment Resource Center; 2000.
43. Hughes PH, Conard SE, Baldwin DC Jr, Storr CL, Sheehan DV. Resident physician substance abuse in the United States. JAMA. 1991;165:2069-2073.
44. McAuliffe WE, Rohman M, Breer P, Wyshak G, Santangelo S, Magnuson E. Alcohol use and abuse in random samples of physicians and medical students. Am J Public Health. 1991;81:177-182.
45. Walzer RS. Impaired physicians: an overview and update of the legal issues. J Leg Med. 1990;11:131-198.
46. Harper CR. Airline pilot alcoholism: one airline's experience. Aviation Space Environ Med. 1983;54:590-591.
47. Reading E. Nine years experience with chemically dependent physicians: the New Jersey experience. Md Med. 1992;41:325-329.
48. Shore JH. The impaired physicians: four years after probation. JAMA. 1982;248:3127-3130.
49. Morse RM, Martin MA, Swenson WM, Neven RG. Prognosis of physicians treated for alcoholism and drug dependence. JAMA. 1984;251:743-746.
50. Graham J, Kazlauskas R. Sports drug testing - an analyst's perspective. Chem Soc Rev. 2004;33:1-13.
51. Talalay S, "NFL Helps Pick Legal Supplements," Sports Business, South Florida Sun Sentinel, p. 19c, Fort Lauderdale, FL, December 12, 2004.
52. Major League Baseball, Inc. Memo distributed to all Major League Baseball Clubs by Bud Selig, Chairman of Major League Baseball. May 15, 1997.
53. Ondersma SJ, Malcoe LH, Simpson SM. Child protective services' response to prenatal drug exposure: results from a nationwide survey. Child Abuse Negl. 2001;25:657-668.
54. Egelko S, Galanter M, Edwards H, Marinelli K. Treatment of perinatal cocaine addiction: use of the modified therapeutic community. Am J Drug Alcohol Abuse. 1996;22:185-202.
55. Nishimoto RH, Roberts AC. Coercion and drug treatment for postpartem women. Am J Drug Alcohol Abuse. 2001;27:161-181.
56. Collins JJ, Allison M. Legal coercion and retention in drug abuse treatment. Hosp Community Psychiatry. 1983;34:1145-1149.
57. Brizer DA, Maslansky R, Galanter M. Treatment retention of patients referred by public assistance to an alcoholism clinic. Am J Drug Alcohol Abuse. 1990;16:259-264.
58. Brecht ML, Anglin MD, Wang JC. Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients. Am J Drug Alcohol Abuse. 1993;19:89-106.
59. Ker M, Leischow S, Markowitz IB, Merikle E. Involuntary smoking cessation: a treatment option in chemical dependency programs for women and children. J Psychoactive Drugs. 1996;28:47-60.
60. Windsor RA, Orleans CT. Guidelines and methodological standards for smoking cessation intervention research among pregnant women: improving the science and art. Health Ed Q. 1986;13:131-161.
61. McKay JR, McLellan AT, Durell J, et al. Characteristics of recipients of supplemental security income (SSI) benefits for drug addicts and alcoholics. J Nerv Ment Dis. 1998;186:290-298.
62. Rosenheck R, Frisman L. Do public support payments encourage substance abuse? Health Aff. 1996;15:192-200.
63. Sennott CM, Murphy SP. SSI checks often used for drink, drugs. Boston Globe: February 26, 1994;19.
64. Satel S, Reuter P, Hartley D, Rosenheck R, Mintz J. Influence of retroactive disability payments on recipients' compliance with substance abuse treatment. Psychiatr Serv. 1997;48:796-799.
65. Satel S. When disability benefits make patients sicker. N Engl J Med. 1995;333:794-796.
66. Rosenheck R. Disability payments and chemical dependence: conflicting values and uncertain effects. Psychiatric Serv. 1997;48:789-791.
67. Phillips DP, Christenfeld N, Ryan NM. An increase in the number of deaths in the United States in the first week of the month - an association with substance abuse and other causes of death. N Engl J Med. 1999;341:93-98.
68. Shaner A, Eckman TA, Roberts LJ, et al. Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers - a government-sponsored revolving door? N Engl J Med. 1995;333:777-783.
69. Frisman LK, Rosenheck R. The relationship of public support payments to substance abuse among homeless veterans with mental illness. Psychiatr Serv. 1997;48:792-795.
70. Alterman AI, Shen Q, Merrill JC, et al. Treatment services received by Supplemental Security Income drug and alcoholic clients. J Subst Abuse Treat. 2000;18:209-215.
71. Watkins KE, Wells KB, McLellan AT. Termination of Social Security benefits among Los Angeles recipients disabled by substance abuse. Psychiatr Serv. 1999;50:914-918.
72. Swartz JA, Lurigio AJ, Goldstein P. Severe mental illness and substance use disorders among former Supplemental Security Income beneficiaries for drug addiction and alcoholism. Arch Gen Psychiatry. 2000;57:701-707.
73. Watkins KE, Podus D. The impact of terminating disability benefits for substance abusers on substance use and treatment participation. Psychiatr Serv. 2000;51:1371-1381.
74. Watkins KE, Podus D, Lombardi E, Burnam A. Changes in mental health and service after termination of SSI benefits. Psychiatr Serv. 2001;52:1210-1215.
75. Ries RK, Short RA, Dyck DG, Srebnik DS. Unlinking disability income, substance use, and adverse outcomes in dually diagnosed, severely mentally ill outpatients. Am J Addict. 2004;113:390-397.